Early intervention for major depressive disorder could lead to better outcomes

Written by Zoe Campbell

Real-world data, presented at the American Psychiatric Association Meeting (18–22 May 2019; CA, USA), suggests that treatment in the year prior to diagnosis of suicide ideation or attempt is markedly low for adult patients with major depressive disorder. Real-world data from three studies, from Janssen Pharmaceutical Companies (Beerse, Belgium), suggests that there is a need to increase and improve interventions for adult patients with major depressive disorder (MDD). In their findings, they saw that treatments for these patients were noticeably low a year prior to diagnosis of suicide prevention or attempt. “Sadly, approximately 47,000 people in the US died by...

To view the full article, please register now for access

It's completely free